Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and NeckWaun Ki Hong, Helmuth Goepfert, S. M. Lippman et al.|New England Journal of Medicine|1990Cited by 1.4k
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue CoalitionGregory A. Curt, Nicholas J. Vogelzang, William Breitbart et al.|The Oncologist|2000Cited by 1.3k
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.Nicholas J. Vogelzang, Russell K. Portenoy, William Breitbart et al.|PubMed|1997Cited by 771
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint InhibitorsScott T. Tagawa, Petros Grivas, Arjun Vasant Balar et al.|Journal of Clinical Oncology|2021Cited by 530
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancerAditya Bardia, Sara A. Hurvitz, Sara M. Tolaney et al.|Annals of Oncology|2021Cited by 294